Viz.ai has received FDA approval for an artificial intelligence algorithm that can spot HCM from a standard electrocardiogram or EKG.
The algorithm automatically reviews EKGs as they are performed, and alerts the cardiology care team if it identifies a patient with suspected HCM. Then, the care team is able to follow up with the patient and conduct further testing, if deemed appropriate.
The technology was developed through a collaboration between Viz.ai and Bristol Myers Squibb that was announced earlier this year.
HCM Beat 